CBR has established a new Scientific and Medical Advisory Board (SMAB), headed by the top minds in the fields of regenerative medicine, transplant medicine, infertility and clinical research. The SMAB will help guide and advance CBR’s mission to unlock the potential of newborn stem cells and expand the range and use of stem cell therapies for patients and their families.
The new board is charged with advising CBR on research, clinical trial partnerships, as well as scientific and new technology investments with the goal of advancing innovation in the field of newborn stem cell science and furthering the translation of research into medical practice.
The four founding members of CBR’s Scientific and Medical Advisory Board are:
Dr. Mahendra Rao MD, PhD
Currently Vice President for Regenerative Medicine at The New York Stem Cell Foundation Research Institute, Dr. Rao previously served as the Director of the National Institute of Health (NIH) Center for Regenerative Medicine. Dr. Rao will serve as the inaugural chairman of the SMAB and act as CBR’s chief clinical and regulatory advisor.
Dr. Charles S. Cox Jr, MD
Currently the University of Texas at Houston’s George and Cynthia Mitchell Distinguished Chair in Neurosciences, Dr. Cox is also Director of the Children’s Program in Regenerative Medicine, Professor of the Department of Pediatric Surgery, and directs the Pediatric Trauma Program at University of TX – Houston/Children’s Memorial Hermann Hospital in the TX Medical Center.
Dr. Leslie Silberstein, MD
Currently Professor of Pathology at Harvard Medical School, Dr. Silberstein is also Director of the Joint Program in Transfusion Medicine at Children’s Hospital Boston, Brigham and Women’s Hospital and the Dana-Farber Cancer Institute Director of the Center for Human Cell Therapy at the Immune Disease Institute/Programs in Cellular and Molecular Medicine at Children’s Hospital Boston.
Dr. Alan Trounson, PhD, MSc
Currently Emeritus Professor at Monash University, Dr. Trounson is also Distinguished Scientist at the Monash-Prince Henry Institute for Medical Research, and a Fellow of the Australian Academy of Technological Sciences and Engineering, all in Melbourne, Australia. He previously served as President of The California Institute of Regenerative Medicine (CIRM), the largest scientific funding body for stem cell research in the world.
We are extremely fortunate to be able to collaborate with four of the world’s leading stem cell experts – it demonstrates the company’s commitment to accelerating stem cell research and improving patients’ lives. – Geoffrey Crouse, CBR President & CEO
The formation of the Scientific and Medical Advisory Board is a significant milestone in the evolution of CBR as a regenerative medicine company and another reason CBR is more than a cord blood bank, it is invested in the future of newborn stem cell science.